Prognostic factors associated with mortality before and during anti-tuberculosis treatment

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 10, 2013, Pages 1310-1316

  Yen, Y F ^a,b   Yen, M Y ^a   Shih, H C ^a   Hu, B S ^a   Ho, B L ^a   Li, L H ^a   Hsiao, J C ^a   Deng, Chung Yeh ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Mortality; Taiwan; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; AGE; ARTICLE; AWARENESS; BACTERIUM CULTURE; COHORT ANALYSIS; EDUCATION; FEMALE; GENDER; HIGH SCHOOL; HUMAN; LUNG CAVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; SOCIAL STATUS; TAIWAN; THORAX RADIOGRAPHY; TREATMENT DURATION; UNEMPLOYMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; COHORT STUDIES; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84884632556     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0888     Document Type: Article

References (35)

1. World Health Organization. Global tuberculosis report, 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012. http://www.who.int/tb/ publications/global-report/gtbr12-main.pdf Accessed June 2013.
2. Taiwan Centers for Disease Control and Prevention. [Promulgated definitions of TB]. Taipei, Taiwan: CDC, 2013. http://nidss.cdc.gov.tw/ singledisease.aspx?pt=s&dc=1&dt=3&disease=010. Accessed June 2013. [Chinese].
3. Chiang C-Y, Enarson D A, Yang S-L, Suo J, Lin T-P. The impact of national health insurance on the notifi cation of tuberculosis in Taiwan. Int J Tuberc Lung Dis 2002; 6: 974-979.
4. Yen Y-F, Rodwell T C, Yen M-Y, et al. DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008. Int J Tuberc Lung Dis 2012; 16: 178-184.
5. Jonnalagada S, Harries A D, Zachariah R, et al. The timing of death in patients with tuberculosis who die during antit uberculosis treatment in Andhra Pradesh, South India. BMC Public Health 2011; 11: 921.
6. Anuwatnonthakate A, Limsomboon P, Nateniyom S, et al. Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS ONE 2008; 3: e3089.
7. Harries A D, Hargreaves N J, Gausi F, Kwanjana J H, Salaniponi F M. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001; 5: 1000-1005.
8. Marks S M, Magee E, Robison V. Patients diagnosed with tuberculosis at death or who died during therapy: Association with the human immunodefi ciency virus. Int J Tuberc Lung Dis 2011; 15: 465-470.
9. Waitt C J, Squire S B. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 2011; 15: 871-885.
10. World Health Organization. Global tuberculosis control. WHO report 1999. WHO/CDS/CPC/TB/99.259. Geneva, Switzerland: WHO, 1999.
11. Nguyen L T, Hamilton C D, Xia Q, Stout J E. Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003. Int J Tuberc Lung Dis 2011; 15: 257-262.
12. Wang C S, Chen H C, Yang C J, et al. The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in Taiwan. Infection 2008; 36: 335-340.
13. Chiang C-Y, Chang C-T, Chang R-E, Li C-T, Huang R-M. Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan. Int J Tuberc Lung Dis 2005; 9: 1006-1012.
14. Field S K, Fisher D, Cowie R L. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004; 126: 566-581.
15. Hauer B, Brodhun B, Altmann D, Fiebig L, Loddenkemper R, Haas W. Tuberculosis in the elderly in Germany. Eur Respir J 2011; 38: 467-470.
16. Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K. Xpert MTB/RIF for diagnosis of TB and drug-resistant TB: A cost and affordability analysis. Eur Respir J 2012; Dec 20. [Epub ahead of print].
17. Centers for Disease Control and Prevention. Updated guidelines for the use of nucleic acid amplifi cation tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009; 58: 7-10.
18. Younis M Z, Rivers P A, Fottler M D. The impact of HMO and hospital competition on hospital costs. J Health Care Finance 2005; 31: 60-74.
19. Hoa N P, Diwan V K, Co N V, Thorson A E K. Knowledge about tuberculosis and its treatment among new pulmonary TB patients in the north and central regions of Vietnam. Int J Tuberc Lung Dis 2004; 8: 603-608.
20. Elzinga G, Raviglione M C, Maher D. Scale up: meeting targets in global tuberculosis control. Lancet 2004; 363: 814-819.
21. Jimenez-Corona M E, Garcia-Garcia L, DeRiemer K, et al. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax 2006; 61: 348-353.
22. Balasubramanian R, Garg R, Santha T, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis 2004; 8: 323-332.
23. Faustini A, Hall A J, Mantovani J, Sangalli M, Perucci C A. Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: A six-year follow-up study. Int J Infect Dis 2008; 12: 611-621.
24. Belo M T, Luiz R R, Hanson C, et al. Tuberculosis and gender in a priority city in the state of Rio de Janeiro, Brazil. J Bras Pneumol 2010; 36: 621-625.
25. Kamel M I, Rashed S, Foda N, Mohie A, Loutfy M. Gender differences in health care utilization and outcome of respiratory tuberculosis in Alexandria. East Mediterr Health J 2003; 9: 741-756.
26. Chern J P, Chen D R, Wen T H. Delayed treatment of diagnosed pulmonary tuberculosis in Taiwan. BMC Public Health 2008; 8: 236.
27. Lin H P, Deng C Y, Chou P. Diagnosis and treatment delay among pulmonary tuberculosis patients identifi ed using the Taiwan reporting enquiry system, 2002-2006. BMC Public Health 2009; 9: 55.
28. Jensen P A, Lambert L A, Iademarco M F, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54: 1-141.
29. Barnes P F, Verdegem T D, Vachon L A, Leedom J M, Overturf G D. Chest roentgenogram in pulmonary tuberculosis. New data on an old test. Chest 1988; 94: 316-320.
30. Pehme L, Rahu K, Rahu M, Altraja A. Factors related to health system delays in the diagnosis of pulmonary tuberculosis in Estonia. Int J Tuberc Lung Dis 2007; 11: 275-281.
31. Brown M, Varia H, Bassett P, Davidson R N, Wall R, Pasvol G. Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate. Clin Infect Dis 2007; 44: 1415-1420.
32. Cuevas L E, Al-Sonboli N, Lawson L, et al. LED fl uorescence microscopy for the diagnosis of pulmonary tuberculosis: A multi-country cross-sectional evaluation. PLoS Med 2011; 8: e1001057.
33. Pepper D J, Marais S, Wilkinson R J, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS ONE 2011; 6: e19484.
34. Kliiman K, Altraja A. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14: 454-463.
35. Joint United Nations Programme on HIV/AIDS. Report on the global HIV/AIDS epidemic. Geneva, Switzerland: UNAIDS, 2009.